Advocacy – HKAPI

26 Aug 25

Preserving Trust: AI and Data Privacy in Healthcare

On 26 August 2025, the Hong Kong Association of the Pharmaceutical Industry (HKAPI) and Cyberport co-hosted “Preserving Trust: AI and Data Privacy in Healthcare” at Cyberport. The event brought together experts from healthcare, technology, academia, and data governance to explore how Artificial Intelligence (AI) is reshaping healthcare while ensuring patient privacy and public trust.

15 Aug 25

CEO Meeting: Understanding the IMACE & Policy Address

On 15 August 2025, the HKAPI hosted its 4th CEO Meeting of the 2024–2026 term, bringing together General Managers, CEOs, and Directors from 15 member companies.

12 Feb 25

Visiting GBAICTI: Paving the Way for Cross-Boundary Clinical Trials

On 12 February 2025, around 30 delegates from 20 member companies visited GBAICTI and HTCZ.

24 Aug 24

HKAPI Supports Primary Healthcare Development Through Health Day Event

We are delighted to announce our collaboration with the HKU LKS Faculty of Medicine's Department of Pharmacology and Pharmacy, the Jockey Club PHARM+ Community Medication Service Network, the Sha Tin District Health Centre Express, and our Associate Member, Chinachem Group, to organize a health day event for the elderly residents of Golden Lion Garden.

13 Oct 23

Guangdong Innovation and Development of Pharmaceutical and Medical Device Forum

Ms Sabrina Chan, Senior Executive Director of HKAPI, represented the Association to be one of the panellists of the Forum.

16 Feb 23

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.

11 Nov 22

Asia Summit on Global Health 2022

Asia Summit on Global Health 2022 It is a great privilege for The Hong Kong Association of the Pharmaceutical Industry to join the Asia Summit on Global Health 2022 organized […]

07 Jul 22

Event: The Journey of Biotech Innovation and Investment in Hong Kong

The Hong Kong Association of the Pharmaceutical Industry (HKAPI) is delighted to be one of the supporting organizations of the hybrid event hosted by InvestHK - “The Journey of Biotech Innovation and Investment in Hong Kong” on 7 July.

02 Jun 22

Tackling the Threat of Antimicrobial Resistance

The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.

11 Mar 22

Can you buy parallel-imported drugs?

There are pharmacies in the market selling drugs which claim to be produced by the same pharmaceutical company but are sold overseas. Can we buy those drugs?

Preserving Trust: AI and Data Privacy in Healthcare

CEO Meeting: Understanding the IMACE & Policy Address

Visiting GBAICTI: Paving the Way for Cross-Boundary Clinical Trials

HKAPI Supports Primary Healthcare Development Through Health Day Event

Guangdong Innovation and Development of Pharmaceutical and Medical Device Forum

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

Asia Summit on Global Health 2022

Event: The Journey of Biotech Innovation and Investment in Hong Kong

Tackling the Threat of Antimicrobial Resistance

Can you buy parallel-imported drugs?

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use